Td Ameritrade Investment Management, LLC Gilead Sciences, Inc. Transaction History

Td Ameritrade Investment Management, LLC

$0
Q3 2023

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $218,270 - $238,137	-2,952 Closed	0 $0
Q2 2023 Aug 09, 2023	SELL	$76.01 - $86.7 $42,641 - $48,638	-561 Reduced 15.97%	2,952 $228,000
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $54,348 - $61,920	-703 Reduced 16.67%	3,513 $291,000
Q4 2022 Feb 09, 2023	SELL	$62.32 - $89.47 $68,614 - $98,506	-1,101 Reduced 20.71%	4,216 $362,000
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $67,696 - $77,327	-1,137 Reduced 17.62%	5,317 $328,000
Q2 2022 Aug 09, 2022	SELL	$57.72 - $65.01 $303,664 - $342,017	-5,261 Reduced 44.91%	6,454 $399,000
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $33,072 - $41,443	571 Added 5.12%	11,715 $696,000
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $230,388 - $261,495	3,551 Added 46.77%	11,144 $809,000
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $302,574 - $326,444	4,470 Added 143.13%	7,593 $480,000
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $30,592 - $33,426	482 Added 18.25%	3,123 $215,000
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $280,530 - $319,651	-4,952 Reduced 65.22%	2,641 $154,000
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $30,863 - $38,805	-497 Reduced 6.14%	7,593 $480,000
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $67,276 - $78,120	-930 Reduced 10.31%	8,090 $622,000
Q1 2020 May 13, 2020	BUY	$62.63 - $80.22 $5,010 - $6,417	80 Added 0.89%	9,020 $674,000
Q4 2019 Feb 07, 2020	BUY	$61.62 - $67.78 $100,810 - $110,888	1,636 Added 22.4%	8,940 $581,000
Q3 2019 Nov 07, 2019	BUY	$62.51 - $69.0 $126,895 - $140,070	2,030 Added 38.49%	7,304 $463,000
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $82,410 - $92,414	1,332 Added 33.79%	5,274 $356,000
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $58,340 - $65,356	933 Added 31.01%	3,942 $256,000
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $122,835 - $160,291	2,029 Added 207.04%	3,009 $188,000
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $69,854 - $77,341	980 New	980 $76,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Ameritrade Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Ameritrade Investment Management, LLC with notifications on news.

Account